What Rate Is SVT? Typical Heart Rate Range

Supraventricular tachycardia, or SVT, typically drives the heart rate to somewhere between 150 and 250 beats per minute, though rates as low as about 110 bpm and occasionally above 250 bpm have been documented. One study that measured heart rates during SVT episodes induced in an electrophysiology lab recorded a range of 108 to 228 bpm.¹ That is a wide spread, and where your own rate falls during an episode depends on the specific type of SVT you have, your age, and the state of your heart’s conduction system.

Why the Range Is So Wide

SVT is not a single arrhythmia. It is an umbrella term covering several distinct rhythm problems that all originate above the ventricles. The most common type, called AV nodal reentrant tachycardia (AVNRT), involves a short circuit within the AV node itself. The second most common is AV reentrant tachycardia (AVRT), which uses an extra electrical pathway between the atria and ventricles. AVRT is the arrhythmia seen in people with Wolff-Parkinson-White (WPW) syndrome, and the orthodox form of it can be triggered in roughly 55% of WPW patients.² Atrial tachycardia and atrial flutter round out the group, each with its own circuit and its own tendency toward particular rate ranges.

Each of these circuits has different electrical properties. A short circuit with a fast loop time can sustain a higher heart rate than one with a longer loop. Individual variation in how quickly the AV node and surrounding tissues conduct electricity explains why one person’s AVNRT might run at 160 bpm while another person’s runs at 220 bpm. Age matters too: younger hearts tend to conduct faster, so SVT episodes in teenagers and young adults often hit the upper end of the range, while older adults with slower conduction tissue sometimes experience rates closer to 140 or 150 bpm.

What Happens Inside Your Body During an Episode

A heart rate of 180 bpm or higher does not just feel alarming. It actually changes the way blood moves through your body. A classic hemodynamic study induced SVT in patients and measured what happened. During normal sinus rhythm, average heart rate was 79 bpm, blood pressure averaged 141 mmHg systolic, and cardiac output was normal. Once SVT kicked in at a mean rate of 183 bpm, systolic blood pressure dropped to about 99 mmHg and cardiac output fell by roughly 40%.³ That drop explains the lightheadedness, near-fainting, and chest pressure that people commonly report during SVT.

The reason for such a dramatic drop is partly mechanical. When the heart beats that fast, the ventricles do not have enough time to fill with blood between contractions. Each beat pumps out a smaller volume. On top of that, the timing of atrial and ventricular contraction can go haywire during SVT. In some forms, the atria and ventricles contract almost simultaneously, which means the atria are trying to push blood into ventricles that are already squeezing. Research has shown that SVT types where atrial and ventricular contractions overlap cause a bigger fall in cardiac output than types where the contractions remain properly staggered.⁴ This is why two people can have the same heart rate during SVT but very different symptom severity.

When SVT Rate Becomes Dangerous

Most SVT episodes, while frightening, are not life-threatening in people with otherwise healthy hearts. The real risks emerge under specific circumstances. One concern is heart muscle damage. A study of patients presenting to the emergency department with SVT found that a heart rate above 150 bpm on admission was a strong independent predictor of elevated troponin, a marker of heart muscle injury. Patients with coronary artery disease were especially vulnerable.⁵ For someone with narrowed coronary arteries, the combination of a fast rate (which increases the heart’s oxygen demand) and lower blood pressure (which reduces oxygen supply) can mimic a small heart attack.

A separate and more insidious danger comes from SVT that persists for days, weeks, or months. This is called tachycardia-induced cardiomyopathy, where the chronically elevated heart rate gradually weakens the heart muscle. The good news is that this condition is largely reversible once the arrhythmia is controlled.⁶ Animal studies have demonstrated that the severity of this weakening depends on the rate, the type of tachycardia, and how long it lasts, and that even moderately elevated rates can cause damage if they persist long enough.⁷ In humans, patients with incessant SVT from an accessory pathway who developed cardiomyopathy showed progressive normalization of heart size and function once their tachycardia was cured.⁸

The Challenge of Telling SVT from Other Fast Rhythms

Not every fast heart rhythm above 150 bpm is SVT, and distinguishing SVT from ventricular tachycardia (VT) matters enormously because VT is far more dangerous and requires different treatment. When the electrical signal takes an unusual path, SVT can sometimes produce a wide QRS complex on an ECG, making it look like VT on the monitor. Determining whether a wide complex tachycardia originates in the ventricles or above them is one of the central challenges of acute cardiac care.⁹

Clinicians use a set of ECG criteria to make this call, but the evidence is humbling. A study evaluating established criteria found that while they were highly specific for a diagnosis when they were present, they were not very sensitive individually. About 10% of tachycardias in the study were either misdiagnosed or could not be diagnosed from the ECG alone.¹⁰ For the person experiencing a fast heart rate, this means that an emergency room will typically err on the side of caution and treat a wide complex tachycardia as VT until proven otherwise.

How SVT Episodes Are Stopped

The first line of defense during an SVT episode is a set of physical maneuvers designed to activate the vagus nerve, which slows conduction through the AV node and can break the reentrant circuit. The Valsalva maneuver, where you bear down as if straining, is the most widely used. A modified version, in which you blow hard against resistance while sitting upright and then immediately lie flat with your legs raised, appears to be more effective than the standard technique. The modified approach works by rapidly shifting blood volume, increasing pressure in the left atrium, and triggering baroreceptor reflexes that enhance vagal tone.¹¹ The underlying principle is that strong vagal stimulation increases the refractory period of AV conduction, which interrupts the circuit sustaining the arrhythmia.¹²

When vagal maneuvers fail, adenosine is the standard drug given intravenously. It entered mainstream clinical use in the 1980s and remains the go-to agent because it briefly blocks conduction through the AV node, interrupting the circuit that maintains most SVT types.¹³ Adenosine has an extremely short half-life, meaning its effects last only seconds, which makes it both effective and safe for most patients. Beyond terminating the arrhythmia, adenosine serves a diagnostic role: the brief AV block it creates can reveal underlying rhythms like atrial flutter that were previously hidden behind fast ventricular rates.¹⁴

Catheter Ablation and Long-Term Cure

For people with frequent or debilitating SVT episodes, catheter ablation offers a realistic chance of cure. During the procedure, a thin catheter is threaded into the heart, the problematic circuit is mapped, and radiofrequency energy is used to destroy the tissue sustaining it. In a five-year registry of 381 patients who underwent ablation, the target tachycardia was successfully terminated in 96% of cases. About 7% of those patients experienced a recurrence afterward, and nearly all of those who recurred were successfully treated with a repeat procedure.¹⁵

Recurrence rates vary depending on where the problematic circuit is located. In a pediatric study tracking outcomes over 12 months, the overall recurrence rate was about 11%, but it ranged from under 5% for AVNRT and left-sided pathways to nearly 25% for right septal pathways.¹⁶ Right septal pathways sit close to the AV node, so operators sometimes have to be conservative with energy delivery to avoid damaging normal conduction, which makes recurrence more likely. If you are told that ablation “works 95% of the time,” that is accurate as an overall figure, but your individual odds depend on the specific circuit involved.

Can a Smartwatch Detect SVT

Many people first notice a fast heart rate through a wearable device rather than an ECG. The question of whether consumer wrist-worn sensors can accurately measure heart rate during SVT is worth asking, since optical sensors work differently from electrodes and can struggle with irregular or very fast rhythms. In a study that compared smartwatch readings against ECG during induced SVT episodes ranging from 108 to 228 bpm, the Apple Watch was accurate to within 10 bpm of the ECG in 100% of SVT episodes, the Galaxy watch in 90%, and the Fitbit in 87%.¹ A separate study testing devices during various arrhythmias found similar results, with both smartwatch brands detecting SVT heart rates in roughly 86 to 89% of episodes.¹⁷

This means that if your smartwatch suddenly reads 180 bpm while you are sitting still, it is probably capturing a real rhythm disturbance rather than a sensor glitch. The caveat is that a wrist sensor can tell you the rate but cannot tell you the type. A reading of 190 bpm could be SVT, VT, or even atrial fibrillation with a rapid ventricular response. A 12-lead ECG remains the only reliable way to distinguish between these, so a smartwatch alert is a reason to seek medical evaluation, not a diagnosis in itself.

SVT During Pregnancy

Pregnancy is a well-recognized trigger for new-onset or recurrent SVT. The body’s cardiovascular adaptations during pregnancy, including a higher resting heart rate, expanded blood volume, and increased cardiac output, all make it easier for reentrant circuits to fire. Supraventricular arrhythmia is in fact the most common form of arrhythmia during pregnancy.¹⁸

Managing SVT in a pregnant patient involves some unique considerations. Intravenous adenosine can be used safely in all three trimesters and during labor. Some oral medications used for prevention, such as atenolol and verapamil, are effective in the second and third trimesters but are contraindicated in the first trimester due to concerns about fetal development. Electrical cardioversion, where a controlled shock resets the heart rhythm, is considered safe throughout pregnancy, although in the third trimester it carries a small risk of triggering preterm labor.¹⁹ Catheter ablation can be performed during pregnancy when necessary, ideally using imaging techniques that avoid radiation exposure to the fetus.¹⁸ In some cases, especially late in pregnancy, the most practical option is simply to deliver the baby, which removes the physiological triggers driving the arrhythmia.

The Autonomic Nervous System and What Triggers Episodes

People with SVT often notice that episodes seem to come out of nowhere, but certain physiological states clearly make them more likely. The autonomic nervous system, which controls unconscious functions like heart rate and blood pressure, plays a significant role. Research comparing SVT patients who also developed episodes of atrial fibrillation with those who did not found that a specific marker of autonomic function, the baroreflex sensitivity, was dramatically higher in the group prone to atrial fibrillation. A baroreflex sensitivity above a certain threshold was associated with a 16-fold increase in the odds of developing paroxysmal atrial fibrillation among SVT patients.²⁰

In practical terms, this means that situations producing strong swings in autonomic tone, like sudden positional changes, emotional stress, sleep deprivation, or stimulant intake, are common triggers. Many SVT patients learn to identify their own personal triggers over time, and while avoiding those triggers does not eliminate the underlying circuit, it can reduce how often it fires. Exercise is a frequent concern: the elevated heart rate during a workout can feel indistinguishable from an SVT episode, and sometimes exercise genuinely does trigger one. Learning to check your pulse for regularity, rather than just speed, can help you tell the difference. SVT produces a rock-steady rapid pulse, while a normal exercise heart rate usually rises and falls smoothly with effort. If you feel a sudden jump from a comfortable rate to one that seems impossibly fast while doing moderate activity, SVT is a more likely explanation than simple exertion.